EndoSound™ Inc., Appoints Medical Device Commercial Leader Scott Aldrich Jr as Chief Executive Officer

Aldrich’s proven commercial, operational and leadership expertise helps position EndoSound for EVS launch and sustainable growth


PORTLAND, Ore.–(BUSINESS WIRE)–EndoSound™ Inc., a pioneering medical technology company dedicated to advancing patient care, is pleased to announce the appointment of Scott Aldrich Jr as Chief Executive Officer on February 1st, 2024. Mr Aldrich is joining EndoSound from MotusGI (Nasdaq: MOTS) where he served as Vice President of Commercial and Strategy. Stephen Steinberg MD will remain on the executive leadership team as Chief Medical Officer.

Mr Aldrich brings operational and commercial leadership abilities paired with extensive experience in interventional gastroenterology and medical device imaging. Furthermore, Mr. Aldrich is a seasoned executive with experience in startup organizations, as well as, small/mid cap companies that are both privately and publicly held. He has established a reputation as an authentic leader with the ability to drive execution through clear organizational vision.

Mr Aldrich remarked, “I am honored and humbled to be able to assume the role of CEO. Stephen has done a remarkable job in getting EndoSound so far in its journey. EndoSound EVS™ is a customer-focused product that can reduce aggregate healthcare costs and improve patient experience and lives. It is exciting to be bringing this technology that so clearly can transform the GI market and patient access to endoscopic ultrasound to market. I look forward to working closely with the EndoSound Board of Directors, Stephen, and the rest of the EndoSound team in successfully launching EVS and making the company’s immense potential a reality.”

Stephen Steinberg, MD commented, “We are thrilled to welcome Scott to the team. He brings a wealth of knowledge in areas that will be extremely important to EndoSound’s success. We believe his leadership style, business acumen and passion make him more than capable to build and grow a revolutionary medical device company.”

About EndoSound

EndoSound, Inc., is a privately held company based in Portland, Oregon. EndoSound is dedicated to expanding access to endoscopic ultrasound technology around the world. With its patented design, EndoSound transforms any flexible upper endoscope into a fully functional EUS scope. It is comprised of an experienced team of scientists and engineers, clinicians, and seasoned business professionals with a track record of bringing new medical devices to market.

To learn more about the EVS, please visit endosound.com.

Contacts

For media inquiries, please contact:

Patrick Hurley

VP of Marketing

pr@endosound.com

Staff

Recent Posts

Waystar announces term loan repricing and credit rating upgrades from Fitch, Moody’s, and S&P Global

Reduces Waystar's cost of capital and enhances its ability to allocate free cash flow towards…

7 hours ago

NUTEX HEALTH ANNOUNCES 1-FOR-10 REVERSE STOCK SPLIT

HOUSTON, June 27, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:…

7 hours ago

Chroma Medicine Announces Exclusive License Agreement with the Whitehead Institute for Novel Epigenetic Editing Technology

License provides exclusive access to innovative epigenetic editors and expands the reach of Chroma's platform…

7 hours ago

Pulmonary Fibrosis Foundation’s 2024 PFF Walk Raises Funds Toward a Cure

Nationwide Walk Series Kicks Off July 20 in Pittsburgh CHICAGO, June 27, 2024 /PRNewswire/ --…

7 hours ago

Zoi Capital Founders and Industry Veterans Announce 200 Million Dollar Fund Targeting AI Technologies with Practical Applications for Healthcare

The Venture Capital Firm Set to Expand Investments in Innovative Healthcare Companies NEW YORK, June…

7 hours ago